Vaccine Development Case Study: Dengue Fever

Jan. 12, 2011 - PRLog -- Vacination therapeutics is one of the most powerful tools being used in the war against infectious diseases, as a result, this has become an area of increased pharmaceutical investment. The successful development of this immunological technique is reliant on a well structured approach to clinical development that takes into consideration the vast array of influential factors at each stage in the process.

Sanofi-Pasteur a currently developing a vaccination for Dengue Fever, this will provide a brilliant platform to analyse the methods taken at the various stages of the process. Such methods can be applied to other vaccination development processes.

By attending this Masterclass, you will be able to:

Learn from the dengue fever vaccine development case study

Progress  from lessons learned throughout phases I, II and III

Debate issues surrounding risk management and launch strategy

For further information and the opportunity to register online please visit http://www.smi-online.co.uk/vaccinesclass5.asp

# # #

i have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.